Monsanto Co. (MON) Forecasted to Earn Q1 2017 Earnings of $0.04 Per Share
Monsanto Co. (NYSE:MON) – Equities researchers at Jefferies Group issued their Q1 2017 earnings per share (EPS) estimates for Monsanto in a note issued to investors on Thursday. Jefferies Group analyst L. Alexander forecasts that the brokerage will earn $0.04 per share for the quarter. Jefferies Group has a “Buy” rating on the stock. Jefferies Group also issued estimates for Monsanto’s Q2 2017 earnings at $2.47 EPS, Q3 2017 earnings at $2.04 EPS, Q4 2017 earnings at $0.09 EPS and FY2020 earnings at $7.35 EPS.
Several other equities research analysts have also issued reports on MON. Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $127.00 target price (up from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Argus reaffirmed a “buy” rating and set a $128.00 target price (up from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the company a “sell” rating in a research report on Monday, June 27th. Vetr raised Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 target price for the company in a research report on Monday, June 27th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and set a $118.00 target price on shares of Monsanto in a research report on Thursday, June 30th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. Monsanto presently has an average rating of “Buy” and a consensus target price of $114.67.
Monsanto (NYSE:MON) opened at 103.36 on Friday. The firm has a market cap of $45.23 billion, a P/E ratio of 45.49 and a beta of 1.19. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26. The firm’s 50-day moving average price is $104.86 and its 200 day moving average price is $101.43.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The business earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same quarter in the prior year, the business posted ($0.19) earnings per share. Monsanto’s revenue was up 8.8% compared to the same quarter last year.
Several institutional investors have recently bought and sold shares of the stock. Advisory Services Network LLC boosted its position in Monsanto by 688.3% in the third quarter. Advisory Services Network LLC now owns 7,457 shares of the company’s stock valued at $762,000 after buying an additional 6,511 shares during the period. Franklin Street Advisors Inc. NC boosted its position in Monsanto by 24.7% in the third quarter. Franklin Street Advisors Inc. NC now owns 62,980 shares of the company’s stock valued at $6,437,000 after buying an additional 12,475 shares during the period. Acropolis Investment Management LLC boosted its position in Monsanto by 4.0% in the third quarter. Acropolis Investment Management LLC now owns 3,319 shares of the company’s stock valued at $339,000 after buying an additional 127 shares during the period. Burke & Herbert Bank & Trust Co. boosted its position in Monsanto by 5.5% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 2,606 shares of the company’s stock valued at $266,000 after buying an additional 137 shares during the period. Finally, BNP Paribas Arbitrage SA boosted its position in Monsanto by 5.2% in the third quarter. BNP Paribas Arbitrage SA now owns 308,850 shares of the company’s stock valued at $31,564,000 after buying an additional 15,128 shares during the period. 79.02% of the stock is currently owned by hedge funds and other institutional investors.
In other news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.